Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 352

1.

C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.

Crockett SD, Mott LA, Barry EL, Figueiredo JC, Burke C, Baxter G, Sandler RS, Baron JA.

Cancer Prev Res (Phila). 2014 Aug 21. pii: canprevres.0167.2014. [Epub ahead of print]

PMID:
25145487
[PubMed - as supplied by publisher]
2.

Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.

Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M, Wilkens LR, Loo LW, Van Den Berg D, Kolonel LN, Henderson BE, Keku TO, Sandler RS, Signorello LB, Blot WJ, Newcomb PA, Pande M, Amos CI, West DW, Bézieau S, Berndt SI, Zanke BW, Hsu L; GECCO consortium members:, Lindor NM, Haile RW, Hopper JL, Jenkins MA, Gallinger S, Casey G; CCFR consortium members:, Stenzel SL, Schumacher FR, Peters U, Gruber SB; CORECT consortium members:, Tsugane S, Stram DO, Le Marchand L; GECCO consortium members; CCFR consortium members; CORECT consortium members.

Nat Commun. 2014 Aug 8;5:4613. doi: 10.1038/ncomms5613.

PMID:
25105248
[PubMed - in process]
3.

Reduced Insulin-like Growth Factor I Receptor and Altered Insulin Receptor Isoform mRNAs in Normal Mucosa Predict Colorectal Adenoma Risk.

Santoro MA, Andres SF, Galanko JA, Sandler RS, Keku TO, Lund PK.

Cancer Epidemiol Biomarkers Prev. 2014 Jul 13. [Epub ahead of print]

PMID:
25017244
[PubMed - as supplied by publisher]
4.

Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer.

Carethers JM, Murali B, Yang B, Doctolero RT, Tajima A, Basa R, Smith EJ, Lee M, Janke R, Ngo T, Tejada R, Ji M, Kinseth M, Cabrera BL, Miyai K, Keku TO, Martin CF, Galanko JA, Sandler RS, McGuire KL.

PLoS One. 2014 Jun 23;9(6):e100461. doi: 10.1371/journal.pone.0100461. eCollection 2014.

PMID:
24956473
[PubMed - in process]
Free PMC Article
5.

Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases.

Herfarth HH, Martin CF, Sandler RS, Kappelman MD, Long MD.

Inflamm Bowel Dis. 2014 Jul;20(7):1194-7. doi: 10.1097/MIB.0000000000000077.

PMID:
24865778
[PubMed - in process]
6.

The potential for markers of epithelial-mesenchymal transition to improve colorectal cancer outcomes: a systematic review.

Busch EL, McGraw KA, Sandler RS.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1164-75. doi: 10.1158/1055-9965.EPI-14-0017. Epub 2014 May 3.

PMID:
24793954
[PubMed - in process]
7.

Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans.

Kupfer SS, Skol AD, Hong E, Ludvik A, Kittles RA, Keku TO, Sandler RS, Ellis NA.

Carcinogenesis. 2014 Sep;35(9):2025-30. doi: 10.1093/carcin/bgu088. Epub 2014 Apr 21.

PMID:
24753543
[PubMed - in process]
8.

Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk.

Steck SE, Butler LM, Keku T, Antwi S, Galanko J, Sandler RS, Hu JJ.

Mutat Res Fundam Mol Mech Mutagen. 2014 Apr;762:24-31. doi: 10.1016/j.mrfmmm.2014.02.004. Epub 2014 Mar 7.

PMID:
24607854
[PubMed - indexed for MEDLINE]
9.

Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas.

Nugent JL, McCoy AN, Addamo CJ, Jia W, Sandler RS, Keku TO.

J Proteome Res. 2014 Apr 4;13(4):1921-9. doi: 10.1021/pr4009783. Epub 2014 Mar 21.

PMID:
24601673
[PubMed - in process]
10.

Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.

Pibiri F, Kittles RA, Sandler RS, Keku TO, Kupfer SS, Xicola RM, Llor X, Ellis NA.

Cancer Causes Control. 2014 May;25(5):561-70. doi: 10.1007/s10552-014-0361-y. Epub 2014 Feb 23.

PMID:
24562971
[PubMed - in process]
Free PMC Article
11.

Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas.

Kang M, Peery AF, Locklear C, Galanko JA, Sandler RS, Keku TO.

J Gastroenterol Hepatol Res. 2013 Apr 14;2(4):531-535.

PMID:
24533351
[PubMed]
Free PMC Article
12.

A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.

Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):601-10. doi: 10.1158/1055-9965.EPI-13-1085. Epub 2014 Feb 5.

PMID:
24501379
[PubMed - in process]
13.

Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol.

Layton JB, Klemmer PJ, Christiansen CF, Bomback AS, Baron JA, Sandler RS, Kshirsagar AV.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1514-1521.e3. doi: 10.1016/j.cgh.2014.01.034. Epub 2014 Jan 29.

PMID:
24486407
[PubMed - in process]
14.

Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners).

Randell RL, Long MD, Cook SF, Wrennall CE, Chen W, Martin CF, Anton K, Sandler RS, Kappelman MD.

Inflamm Bowel Dis. 2014 Mar;20(3):541-4. doi: 10.1097/01.MIB.0000441348.32570.34.

PMID:
24451221
[PubMed - in process]
15.

Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.

Kang M, Shen XJ, Kim S, Araujo-Perez F, Galanko JA, Martin CF, Sandler RS, Keku TO.

Cancer Biomark. 2013;13(5):359-66. doi: 10.3233/CBM-130366.

PMID:
24440976
[PubMed - indexed for MEDLINE]
16.

Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement.

Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA.

Inflamm Bowel Dis. 2014 Feb;20(2):246-50. doi: 10.1097/01.MIB.0000437737.68841.87.

PMID:
24374881
[PubMed - in process]
17.

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE.

Inflamm Bowel Dis. 2014 Feb;20(2):398-415. doi: 10.1097/01.MIB.0000435441.30107.8b.

PMID:
24280882
[PubMed - in process]
18.

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Dassopoulos T, Dubinsky MC, Bentsen JL, Martin CF, Galanko JA, Seidman EG, Sandler RS, Hanauer SB.

Aliment Pharmacol Ther. 2014 Jan;39(2):163-75. doi: 10.1111/apt.12555. Epub 2013 Nov 17.

PMID:
24237037
[PubMed - in process]
19.

Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases.

Kappelman MD, Long MD, Martin C, DeWalt DA, Kinneer PM, Chen W, Lewis JD, Sandler RS.

Clin Gastroenterol Hepatol. 2014 Aug;12(8):1315-23.e2. doi: 10.1016/j.cgh.2013.10.019. Epub 2013 Oct 29.

PMID:
24183956
[PubMed - in process]
20.

Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study.

Erichsen R, Sværke C, Sørensen HT, Sandler RS, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1994-9. doi: 10.1158/1055-9965.EPI-13-0444. Epub 2013 Sep 18.

PMID:
24049127
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk